Midwest Annual Conference

Rosemont, IL | October 10-13, 2018

Donald E. Stephens Convention Center

A Clinician’s Guide to the Diagnosis of Autoimmune Connective Tissue Diseases

Description

Autoimmune diseases are the second leading cause of chronic illness, with 80-100 types of disease reported, and affecting approximately 50 million patients in the US. This activity will feature two nationally prominent leaders in rheumatology who are experts in autoimmune diseases biomarker science and clinical management. They will discuss the current trends in autoimmune disorder diagnosis by primary care providers, including etiology, risk assessment, and importance of early diagnosis.

Learning Objectives

Discuss the current trends in autoimmune disorder diagnosis by primary care providers, including etiology, risk assessment, and importance of early diagnosis

Relate the clinical and genetic evidence for the association of biomarkers such as antinuclear antibody (ANA) presence and proper testing algorithms

Ability to diagnosis rheumatic diseases when ANA testing is negative

Gain competence in using and evaluating current biomarkers for diagnosis of early RA

Discuss the new types of biomarker testing available for diagnosing rheumatic diseases and how to interpret the results


Educational Partners

Medtelligence, LLC

Commercial Supporters

Quest Diagnostics